NYSE · Healthcare Plans · USD
The Cigna Group (CI) Stock Analysis
The Cigna Group (CI) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CI Key Statistics
As of Sep 4, 2026Trading
- Open
- $283.06
- Previous Close
- $286.26
- Day's Range
- 281.63–284.67
- 52-Week Range
- 239.51–315.47
- Volume
- 1.20M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.32
Valuation
- Market Cap
- $74.65B
- P/E Ratio
- 11.68
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 8.44
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.78
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.26
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 24.19
Financials (FY)
- Revenue (FY)
- $273.85B+11.26%
- Net Income (FY)
- $5.96B+73.47%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.27%
- Shares Outstanding
- 264.24M
- 1-Year Return
- −5.49%
Dividend and dates
- Dividend
- $6.24+2.18%
- Ex-Dividend Date
- September 8, 2026
- Earnings Date
- November 5, 2026
- Avg Volume
- 1.67M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
CI Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +3.81% |
| 2025 | +1.72% |
| 2024 | −6.27% |
| 2023 | −7.97% |
| 2022 | +46.68% |
| 2021 | +12.29% |
| 2020 | +1.83% |
| 2019 | +7.70% |
| 2018 | −6.46% |
| 2017 | +52.29% |
| 2016 (partial year) | +3.89% |
As of September 4, 2026.
CI Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $273.85B | $5.96B | 2.2% |
| 2024 | $246.15B | $3.43B | 1.4% |
| 2023 | $194.10B | $5.16B | 2.7% |
| 2022 | $179.36B | $6.70B | 3.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $273.85B | $24.51B | $8.15B | $5.96B | 2.2% |
| 2024 | $246.15B | $24.99B | $8.44B | $3.43B | 1.4% |
| 2023 | $194.10B | $24.01B | $7.37B | $5.16B | 2.7% |
| 2022 | $179.36B | $22.35B | $7.30B | $6.70B | 3.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CI Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $3.12 | 2 | — |
| 2025 | $6.04 | 4 | +7.9% |
| 2024 | $5.60 | 4 | +13.8% |
| 2023 | $4.92 | 4 | +9.8% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $3.12 | 2 | — |
| 2025 | $6.04 | 4 | +7.9% |
| 2024 | $5.60 | 4 | +13.8% |
| 2023 | $4.92 | 4 | +9.8% |
| 2022 | $4.48 | 4 | +12.0% |
| 2021 | $4.00 | 4 | +9900.0% |
| 2020 | $0.04 | 1 | +0.0% |
| 2019 | $0.04 | 1 | +0.0% |
| 2018 | $0.04 | 1 | +0.0% |
| 2017 | $0.04 | 1 | — |
Most recent payment: $1.56 per share, ex-dividend June 4, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
CI Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | CI | Healthcare Plans median | vs median |
|---|---|---|---|
| P/E | 11.68 | 25.66 | 54% below |
| P/S ratio | 0.26 | 0.44 | 40% below |
| Profit margin | 2.27% | 1.18% | 1.1 pts above |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
The Bull Case For Cigna Group (CI) Could Change Following Its New Connected Benefits Platform Launch
YahooHow Is The Cigna Group’s Stock Performance Compared to Other Healthcare Plans
YahooBill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose
BenzingaMarket Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest
YahooUNH Stock Gets Cheaper Only If The Margins Come Back
YahooCigna Healthcare Unit Launches Connected Benefits To Cover Costs From Unexpected Or Costly Health Events By Bringing Medical And Supplemental Health Benefits Together
Benzinga
All 20 articles ↓Show fewer ↑
‘I Still Subsidize Every Script': Billionaire Mark Cuban Admits He Is Personally Helping Pay for the Prescriptions for Millions of Americans
YahooZacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina
YahooIs The Pullback In UNH Stock A Glitch Or A Warning?
YahooMark Cuban: “No Chance” Radiologists Get Replaced by AI. He Says the Real Target Is Elsewhere
YahooHims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash
YahooQ2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
YahooCigna: I'm Buying What Others Are Ignoring
SeekingAlphaMark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs
BenzingaThe Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan
YahooElizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration
BenzingaOscar Health Stock Has Doubled This Year. The ACA Insurer Reports Thursday.
YahooThe Case For UnitedHealth Stock Is Margin, Not Growth
YahooUnitedHealth Stock Ran On A Repricing The Company Described In Advance
YahooIs Stronger Q2 Earnings And Outlook Revision Altering The Investment Case For Cigna Group (CI)?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Healthcare Plans Stocks
UnitedHealth Group Incorporated
$356.47B
CVSCVS Health Corporation
$123.73B
ELVElevance Health, Inc.
$88.37B
HUMHumana Inc.
$48.22B
CNCCentene Corporation
$33.12B
MOHMolina Healthcare, Inc.
$10.48B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
NVSNovartis AG
$304.10B














